湘西地区ACS患者PCI术后他汀类药物依从性及影响因素的研究
A Study on Statin Compliance and Influencing Factors in ACS Patients after PCI in Xiangxi Region
DOI: 10.12677/ACM.2024.141216, PDF,    科研立项经费支持
作者: 黄 盼, 丁建平*:吉首大学医学院,湖南 吉首;张家界市人民医院心血管内科,湖南 张家界;雷雪春:张家界市人民医院心血管内科,湖南 张家界;贾 薇:吉首大学医学院,湖南 吉首
关键词: ACSPCI他汀类药物依从性影响因素ACS PCI Statins Compliance Influencing Factors
摘要: 目的:了解湘西地区ACS患者PCI术后他汀类药物使用依从性现状,探讨其影响因素。方法:通过对2021年06月01日到2022年12月01日期间因ACS在张家界市人民医院行PCI治疗后好转出院6个月的患者进行随访调查,采用多元Logistic回归分析方法对影响他汀类药物服药依从性的影响因素进行分析。结果:本次研究共纳入508例ACS且行PCI术的患者,其中男性352例,女性156例,50岁至70岁的患者占比较高。根据MMAS-8量表评分,其中依从性好组129例,占25.39%;依从性中等组179例,占35.24%;依从性差组200例,占39.37%。服药依从性中等及以上的患者占60.63%。多元Logistic回归分析结果显示性别(OR = 1.551)、年龄(OR = 3.393)、职工医保(OR = 0.158)、生活环境(OR = 0.320)、婚姻状况(OR = 0.156)、退休(OR = 0.001)、学历(OR = 2.541)、是否与子女同居(OR = 3.947)是ACS行PCI术的患者他汀类药物依从性的影响因素。结论:湘西地区行PCI治疗的ACS患者二级预防用药依从性中等以上比例较多,根据其影响因素分析,需要多加关注女性、高龄、居住在农村、文化水平低以及鳏寡患者,采取针对性个体化措施,定期随访,有利于提高他汀类及其他二级预防药物依从性。
Abstract: Objective: To investigate the status quo of statin use compliance in patients with ACS after PCI in Xiangxi region, and to explore the influencing factors. Methods: A six-month follow-up study was conducted on patients who were discharged from Zhangjiajie People’s Hospital after PCI for ACS between June 1, 2021, and December 1, 2022, multiple Logistic regression analysis was used to an-alyze the influencing factors of statin compliance. Results: A total of 508 patients with ACS who un-derwent PCI were included in this study, including 352 men and 156 women, with a higher propor-tion of patients aged 50 to 70 years. According to the score of MMAS-8, there were 129 cases (25.39%) in good compliance group, 179 cases (35.24%) in moderate compliance group, and 200 cases (39.37%) in poor compliance group. 60.63% of the patients had moderate or above compli-ance. Multiple Logistic regression analysis showed that sex (OR = 1.551), age (OR = 3.393), staff health insurance (OR = 0.158), living environment (OR = 0.320), marital status (OR = 0.156), re-tirement (OR = 0.001), education (OR = 2.541) and cohabitation with children (OR = 3.947) were the influencing factors of statin compliance in patients with ACS undergoing PCI. Conclusion: The compliance rate of ACS patients undergoing PCI for secondary prevention in Xiangxi region is more than moderate, we need to pay more attention to women, elderly people, those living in rural areas, those with low education level and those who are widowed or widowed, and take individualized measures and follow up regularly, it is beneficial to improve the compliance of statins and other secondary prevention drugs.
文章引用:黄盼, 丁建平, 雷雪春, 贾薇. 湘西地区ACS患者PCI术后他汀类药物依从性及影响因素的研究[J]. 临床医学进展, 2024, 14(1): 1508-1514. https://doi.org/10.12677/ACM.2024.141216

参考文献

[1] Hoole, S.P. and Bambrough, P. (2020) Recent Advances in Percutaneous Coronary Intervention. Heart, 106, 1380-1386. [Google Scholar] [CrossRef] [PubMed]
[2] Bergmark, B.A., Mathenge, N., Merlini, P.A., Lawrence-Wright, M.B. and Giugliano, R.P. (2022) Acute Coronary Syndromes. The Lancet, 399, 1347-1358. [Google Scholar] [CrossRef
[3] Xu, W., Tu, H., Xiong, X., Peng, Y. and Cheng, T. (2022) Predicting the Risk of Unplanned Readmission at 30 Days after PCI: Development and Validation of a New Predictive Nomogram. Clinical Interventions in Aging, 17, 1013-1023. [Google Scholar] [CrossRef
[4] Freites, A., Hernando, L., Salinas, P., et al. (2023) Incidence and Prog-nosis of Late Readmission after Percutaneous Coronary Intervention. Cardiology Journal, 30, 696-704. [Google Scholar] [CrossRef
[5] 肖红雨. 急性冠脉综合征患者PCI术后二级预防现状研究[D]: [硕士学位论文]. 济南: 山东大学, 2017: 1-62.
[6] Pedretti, R.F.E., Hansen, D., Ambrosetti, M., et al. (2023) How to Optimize the Adherence to a Guideline-Directed Medical Therapy in the Secondary Prevention of Cardiovascular Dis-eases: A Clinical Consensus Statement from the European Association of Preventive Cardiology. European Journal of Preventive Cardiology, 30, 149-166. [Google Scholar] [CrossRef] [PubMed]
[7] Liberale, L., Carbone, F., Montecucco, F. and Sahebkar, A. (2020) Statins Reduce Vascular Inflammation in Atherogenesis: A Review of Underlying Molecular Mechanisms. The Interna-tional Journal of Biochemistry & Cell Biology, 122, Article 105735. [Google Scholar] [CrossRef] [PubMed]
[8] Kouhpeikar, H., Delbari, Z., Sathyapalan, T., Simental-Mendía, L.E., Jamialahmadi, T. and Sahebkar, A. (2020) The Effect of Statins through Mast Cells in the Pathophysiology of Ath-erosclerosis: A Review. Current Atherosclerosis Reports, 22, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
[9] Banach, M., Stulc, T., Dent, R. and Toth, P.P. (2016) Statin Non-Adherence and Residual Cardiovascular Risk: There Is Need for Substantial Improvement. International Journal of Cardiology, 225, 184-196. [Google Scholar] [CrossRef] [PubMed]
[10] 张新超, 于学忠, 陈凤英, 朱华栋. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中国急救医学, 2019, 39(4): 301-308.
[11] Ng, R., Sutradhar, R., Yao, Z., Wodchis, W.P. and Rosella, L.C. (2020) Smoking, Drinking, Diet and Physical Activity-Modifiable Lifestyle Risk Factors and Their Associ-ations with Age to First Chronic Disease. International Journal of Epidemiology, 49, 113-130. [Google Scholar] [CrossRef] [PubMed]
[12] Teixeira, R., Gonçalves, L. and Gersh, B. (2013) Acute Myocardial Infarc-tion—Historical Notes. International Journal of Cardiology, 167, 1825-1834. [Google Scholar] [CrossRef] [PubMed]
[13] 张成彬. 二级预防管理在冠心病PCI术后患者中的应用效果[J]. 国际护理学杂志, 2021, 40(17): 3211-3216.
[14] Guan, Z.W., Wu, K.R., Li, R., et al. (2019) Pharmacogenetics of Statins Treatment: Efficacy and Safety. Journal of Clinical Pharmacy and Therapeutics, 44, 858-867. [Google Scholar] [CrossRef] [PubMed]
[15] Jia, S., Liu, Y. and Yuan, J. (2020) Evidence in Guidelines for Treatment of Coronary Artery Disease. In: Advances in Experimental Medicine and Biology, Vol. 1177, 37-73. [Google Scholar] [CrossRef] [PubMed]
[16] Jin, K., Khonsari, S., Gallagher, R., et al. (2019) Telehealth In-terventions for the Secondary Prevention of Coronary Heart Disease: A Systematic Review and Meta-Analysis. Europe-an Journal of Cardiovascular Nursing, 18, 260-271. [Google Scholar] [CrossRef] [PubMed]
[17] Lewey, J., Shrank, W.H., Bowry, A.D.K., Kilabuk, E., Brennan, T.A. and Choudhry, N.K. (2013) Gender and Racial Disparities in Adherence to Statintherapy: A Meta-Analysis. Amer-ican Heart Journal, 165, 665-678.e1. [Google Scholar] [CrossRef] [PubMed]
[18] 卫攀, 郭晓岚, 尹姣, 等. 冠心病患者疾病感知和用药依从性的调查研究[J]. 上海护理, 2021, 21(5): 46-48.
[19] Jin, H., Tang, C., Wei, Q., et al. (2014) Age-Related Differences in Factors Associated with the Underuse of Recommended Medications in Acute Coronary Syndrome Patients at Least One Year after Hospital Discharge. BMC Cardiovascular Disorders, 14, Article No. 127. [Google Scholar] [CrossRef] [PubMed]
[20] Ohm, J., Skoglund, P.H., Discacciati, A., et al. (2018) Socioeco-nomic Status Predicts Second Cardiovascular Event in 29,226 Survivors of a First Myocardial Infarction. European Journal of Preventive Cardiology, 25, 985-993. [Google Scholar] [CrossRef] [PubMed]
[21] 刘海威. 农村区域急性冠脉综合征PCI术后患者院外综合管理模式的研究[D]: [硕士学位论文]. 扬州: 扬州大学, 2021.
[22] 周雅楠, 崔玉顺, 齐海峰, 等. 健康素养对再发急性冠状动脉综合征患者冠心病二级预防依从性的影响[J]. 延边大学医学学报, 2023, 46(1): 40-44.
[23] 盛昌余. 冠心病二级预防研究体会与进展[J]. 医学食疗与健康, 2022, 20(24): 163-166.